250 related articles for article (PubMed ID: 28329304)
21. IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis.
VanDevanter DR; Morris NJ; Konstan MW
J Cyst Fibros; 2016 May; 15(3):372-9. PubMed ID: 26603642
[TBL] [Abstract][Full Text] [Related]
22. Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007.
Ortiz JR; Neuzil KM; Victor JC; Aitken ML; Goss CH
Chest; 2010 Dec; 138(6):1448-55. PubMed ID: 20495106
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of Respiratory Syncytial Virus Across Five Influenza Seasons Among Adults and Children One Year of Age and Older-Washington State, 2011/2012-2015/2016.
Jackson ML; Scott E; Kuypers J; Nalla AK; Roychoudury P; Chu HY
J Infect Dis; 2021 Jan; 223(1):147-156. PubMed ID: 32556287
[TBL] [Abstract][Full Text] [Related]
24. Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents.
Bosco E; van Aalst R; McConeghy KW; Silva J; Moyo P; Eliot MN; Chit A; Gravenstein S; Zullo AR
JAMA Netw Open; 2021 Jun; 4(6):e2111806. PubMed ID: 34106266
[TBL] [Abstract][Full Text] [Related]
25. Systematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis.
Kua KP; Lee SWH
Pharmacotherapy; 2017 Jun; 37(6):755-769. PubMed ID: 28423192
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
Thornton CS; Caverly LJ; Kalikin LM; Carmody LA; McClellan S; LeBar W; Sanders DB; West NE; Goss CH; Flume PA; Heltshe SL; VanDevanter DR; LiPuma JJ
Ann Am Thorac Soc; 2024 Apr; 21(4):595-603. PubMed ID: 37963297
[No Abstract] [Full Text] [Related]
27. Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?
Jansen AG; Sanders EA; VAN DER Ende A; VAN Loon AM; Hoes AW; Hak E
Epidemiol Infect; 2008 Nov; 136(11):1448-54. PubMed ID: 18211724
[TBL] [Abstract][Full Text] [Related]
28. The Clinical Association between
O'Dea AL; Feng R; Glaser LJ; Kubrak C; Rubenstein RC; Dorgan DJ; Hadjiliadis D; Kawut SM; Hong G
Ann Am Thorac Soc; 2023 Jul; 20(7):984-992. PubMed ID: 36800434
[No Abstract] [Full Text] [Related]
29. Association between serum 25-hydroxyvitamin D level and pulmonary exacerbations in cystic fibrosis.
Vanstone MB; Egan ME; Zhang JH; Carpenter TO
Pediatr Pulmonol; 2015 May; 50(5):441-6. PubMed ID: 25657016
[TBL] [Abstract][Full Text] [Related]
30. Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis.
Giebels K; Marcotte JE; Podoba J; Rousseau C; Denis MH; Fauvel V; Laberge S
Pediatr Pulmonol; 2008 Feb; 43(2):169-74. PubMed ID: 18085710
[TBL] [Abstract][Full Text] [Related]
31. Estimation of influenza and respiratory syncytial virus hospitalizations using sentinel surveillance data-La Paz, Bolivia. 2012-2017.
Chavez D; Gonzales-Armayo V; Mendoza E; Palekar R; Rivera R; Rodriguez A; Salazar C; Veizaga A; Añez A
Influenza Other Respir Viruses; 2019 Sep; 13(5):477-483. PubMed ID: 31206257
[TBL] [Abstract][Full Text] [Related]
32. Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
Bjornson C; Chan P; Li A; Paes B; Lanctôt KL; Mitchell I
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1113-1118. PubMed ID: 29557081
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.
Skolnik K; Nguyen A; Somayaji R; Thornton CS; Waddell B; Surette MG; Rabin HR; Parkins MD
BMC Pulm Med; 2015 Dec; 15():161. PubMed ID: 26651825
[TBL] [Abstract][Full Text] [Related]
34. Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.
Cogen JD; Faino AV; Onchiri F; Gibson RL; Hoffman LR; Kronman MP; Rosenfeld M; Nichols DP
Ann Am Thorac Soc; 2021 Feb; 18(2):266-272. PubMed ID: 32810412
[No Abstract] [Full Text] [Related]
35. Respiratory viral infections in Western Australians with cystic fibrosis.
Brestovac B; Lawrence C; Speers DJ; Sammels LM; Mulrennan S
Respir Med; 2020 Jan; 161():105854. PubMed ID: 32056728
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of respiratory syncytial virus activity in children and adults presenting with acute respiratory illness at primary care clinics in Singapore, 2014-2018.
Ang LW; Mak TM; Cui L; Leo YS; Lee VJM; Lin RT
Influenza Other Respir Viruses; 2020 Jul; 14(4):412-419. PubMed ID: 32090482
[TBL] [Abstract][Full Text] [Related]
37. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status.
Matias G; Taylor R; Haguinet F; Schuck-Paim C; Lustig R; Shinde V
Influenza Other Respir Viruses; 2014 Sep; 8(5):507-15. PubMed ID: 24975705
[TBL] [Abstract][Full Text] [Related]
38. A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care.
Sawicki GS; Ayyagari R; Zhang J; Signorovitch JE; Fan L; Swallow E; Latremouille-Viau D; Wu EQ; Shi L
Pediatr Pulmonol; 2013 Oct; 48(10):954-61. PubMed ID: 23255309
[TBL] [Abstract][Full Text] [Related]
39. Burden and epidemiology of influenza- and respiratory syncytial virus-associated severe acute respiratory illness hospitalization in Madagascar, 2011-2016.
Rabarison JH; Tempia S; Harimanana A; Guillebaud J; Razanajatovo NH; Ratsitorahina M; Heraud JM
Influenza Other Respir Viruses; 2019 Mar; 13(2):138-147. PubMed ID: 30596225
[TBL] [Abstract][Full Text] [Related]
40.
Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
